# PZH: Serpina1 Variant Detection System

- Device class: 2; regulation: 21 CFR 866.5130; FDA's rule: 510(k) required
- FDA decisions: 3
- 510(k) review time 2021–2025: median 29 days (middle half 29–29)
- Recalls: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026; MAUDE to Sep 30, 2026

## Decisions per year (last 10)
- 2017: 1
- 2019: 1
- 2021: 1

## Most-cited predicates
- K192858: A1AT Genotyping Test (2019), cited by 1
- K171868: A1AT Genotyping Test (2017), cited by 1

Source page: https://510kreport.com/product-code/PZH
Data by year (CSV): https://510kreport.com/product-code/PZH.csv